As consumer demand for healthy, convenient and tasty food choices increase, so too does the demand for California Figs. Though an Ancient fruit and beloved for centuries, figs are on the up rise as a go-to snack and ingredient.
“Figs fit a healthy lifestyle because they’re portable, delicious and nutritious,” says Valerie Waters, celebrity fitness trainer to stars like Jennifer Garner and Cindy Crawford throughout her career. “I encourage my clients to seek out good-for-you food that tastes great so when you see California Figs, buy them!”
California Figs are an excellent source of fiber, and figs contribute essential vitamins and minerals to your diet, including iron, calcium, potassium, magnesium, vitamin B6 and copper. Figs are also fat, sodium and cholesterol-free.
To view the multimedia release go to:
https://www.multivu.com/players/English/8157651-california-figs-valerie-waters-healthy-recipes/
From a child development expert whose pet-centric curriculum is helping rehabilitate troubled adolescents to the founder of New York City’s first cat café, Purina’s third Better With Pets Summit showcased how the relationship between pets and people enhances overall emotional wellness.
The day-long summit, which was hosted by Emmy-nominated comedian and writer, Josh Gondelman, took place at the Brooklyn Expo Center in New York City on Nov. 3 and featured three panel discussions that examined the emotional relationship between pets and people, including the reciprocal effects both have on one another. Keynote speeches were presented by Purina senior research nutritionist Arleigh Reynolds, who has researched the dog and human bond for many years in Alaska and supports of The Frank Attla Youth Program; and author and reality television personality Carole Radziwill, who shared how pet ownership has shaped her life experiences.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7655851-purina-better-with-pets-summit/
BeSmartBeWell.com, an award-winning website, is dedicated to helping the public be healthy and safe through increased awareness and simple-to-use knowledge. In 2009, Be Smart. Be Well. created a series of videos about the childhood obesity crisis. Four years later, we checked in with a leading expert to ask: Are we winning the race?
To view Multimedia News Release, go to http://www.multivu.com/mnr/61019-be-smart-be-well-childhood-obesity-are-we-winning-the-race
NEW YORK, NY (January 28, 2019) – Today, CancerCare celebrated its 75th anniversary by revealing a new campaign “If It Matters To You, It Matters To Us.” The campaign declares CancerCare’s commitment to holistic, patient-centered support services, and celebrates a legacy of comprehensive care for people living with cancer.
“A cancer diagnosis turns a person’s life upside down. Throughout many doctors’ visits, tests and treatments, people with cancer often feel like they’re perceived as a patient rather than a person,” said CancerCare CEO, Patricia Goldsmith. “For 75 years, CancerCare has championed the importance of addressing what matters most to patients and their families through free, direct services to help cope with the emotional, practical and financial challenges of a cancer diagnosis.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8350251-cancercare-75th-anniversary-cancer-community/
Kaléo, a privately-held pharmaceutical company, today announced the AUVI-Q® (epinephrine injection, USP) Auto-injector will be available by prescription starting February 14th, and announced AUVI-Q AffordAbility, a first-of-its-kind access program for AUVI-Q. Through this new program, patients with commercial insurance, even those with high-deductible plans, will have an out-of-pocket cost of $0. For patients who do not have government or commercial insurance, and have a household income of less than $100,000, AUVI-Q will be available free of charge. In addition, the cash price for AUVI-Q is $360 and will be available to those patients without government or commercial insurance. Each AUVI-Q prescription includes two Auto-injectors and one Trainer for AUVI-Q.
To view the multimedia release go to:
http://www.multivu.com/players/English/7981051-auvi-q-epinephrine-auto-injector-access-and-availability-launch/
Blood cancers are the third leading cause of cancer deaths in the U.S. However, many Americans are unaware of the impact of these cancers, including leukemia, lymphoma and myeloma, which affect the bone marrow, the blood cells, the lymph nodes and other parts of the lymphatic system.
A new survey commissioned by The Leukemia & Lymphoma Society (LLS) reveals more than four in five adults (82%) are surprised that blood cancers are the third leading cancer killer of Americans. Further, nearly four in five adults (78%) are surprised that acute lymphocytic leukemia (ALL) is the most common cancer in children and young adults under age 20.
To view the multimedia release go to:
https://www.multivu.com/players/English/8128551-lls-blood-cancer-awareness-month/
Doctors at Qatar’s first specialist women’s and children’s hospital Sidra Medicine have successfully separated conjoined twins, marking a first for the country. The surgery establishes an alternative for patients who previously had limited choices for the successful treatment and care of complex pediatric diseases in the region.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8422651-conjoined-twins-find-new-lease-on-life/
As part of an ongoing commitment to support life sciences innovators and the development of integrated, cross-sector solutions to prevent, intercept and cure diseases, Johnson & Johnson today named cell biologist Yoshinori Ohsumi, Ph.D., of the Tokyo Institute of Technology the winner of the 2016 Dr. Paul Janssen Award for Biomedical Research for his pioneering discoveries concerning the molecular basis of autophagy.
Dr. Ohsumi was honored today during an event at the 2016 BIO International Convention in San Francisco. A video of his acceptance comments can be viewed here.
“Dr. Ohsumi’s curiosity led him to become the first person in the world to determine the molecular mechanism and regulation of autophagy, shedding light on one of the most basic functions of all living cells,” said Paul Stoffels, M.D., Chief Scientific Officer, Johnson & Johnson. “Dr. Ohsumi’s discoveries hold promise for better understanding, preventing and treating many diseases. It is with great pleasure that we celebrate his contributions, which remind us of the innovative spirit Dr. Paul brought to the lab every day.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7856351-2016-dr-paul-janssen-award-ohsumi/
hello® naturally friendly™ oral care is bringing smiles to the aisles of Walmart stores nationwide with its line of kids’ toothpastes. With hello, parents can end brush time negotiations with their kids: kids get flavors so awesome they’ll rush to brush, and parents get thoughtfully selected ingredients they can feel good about, with formulations free from artificial sweeteners, dyes, parabens, triclosan, or microbeads. hello kids fluoride pastes are ADA accepted and clinically proven to prevent cavities and strengthen enamel. For little ones who may swallow paste, or for folks who don’t dig fluoride for their kids, hello has introduced new fluoride and SLS free toothpaste in natural watermelon flavor. hello’s kids’ toothpastes are also available at other great retailers across the US.
Today, hello is sharing the brand’s first ever advertising campaign, including spots that tap into the frustrations and negotiations parents can face when it’s brush time. hello’s kids’ delicious bubble gum and blue raspberry pastes are featured as the no compromise key to a consternation-free brush time in digital units and videos debuting online.
To view the multimedia release go to:
http://www.multivu.com/players/English/7781251-hello-naturally-friendly-kids-toothpastes/
GW Pharmaceuticals plc (Nasdaq: GWPH, “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, along with its U.S. subsidiary Greenwich Biosciences, announced today that The New England Journal of Medicine has published results from a Phase 3 study of Epidiolex® (cannabidiol) in children with Dravet syndrome.1 Epidiolex, GW’s lead product candidate and the potential first in a new category of anti-epileptic drugs, is a liquid formulation of purified, plant-derived cannabidiol (CBD), a non-psychoactive cannabinoid, which is being studied for the treatment of a number of rare, severe pediatric-onset epilepsy disorders. In the study, Epidiolex significantly reduced monthly convulsive seizure frequency compared to placebo in highly treatment-resistant children when added to existing treatment. Treatment with Epidiolex was generally well tolerated, with a safety profile consistent with prior open label experience.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8109951-gw-pharmaceuticals-study-epidiolex/
General Mills is following consumer driven food trends with its line-up of products launching this summer around the world. Many of the new products closely align with increasing consumer interest in wellness, convenience, and snacking including new Yoplait Greek 2% Whips!, Nature Valley Nut & Seed Crunchy Granola Bars, Annie’s organic cereal, Old El Paso Mini Taco Boats, Totino’s Pizza Sticks and Häägen-Dazs Stick Bars.
The company’s broad portfolio of new products can be found in its 2016 New Product Showcase, available on the General Mills corporate blog, A Taste of General Mills: Blog.GeneralMills.com/2016/Summer
“We’re in a period of very rapid change in the food industry. And consumers are very clear about what they want – simple ingredient lists, free from artificial colors and flavors, free from gluten, less sugar, less sodium, more convenience. This translates into very a clear set of growth opportunities for us,” said Ken Powell, General Mills Chairman and Chief Executive Officer. “We’ve challenged ourselves to go out and really understand our consumers, get into their homes, shop alongside them and listen to what they want. These interactions allow us to build greater intuition, which helps us move much faster. Our new product line up demonstrates our ability to listen and respond.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7857151-general-mills-new-2016-products/
SEE International, a nonprofit dedicated to providing essential vision care worldwide, is proud to announce the release of a new short film. Entitled “A Mother’s Wish,” the 7-minute documentary tells the emotional story of Nacor, a 7-year old boy living in a tiny village in Peru. Born with cataracts in both eyes, Nacor was already legally blind. If he did not receive treatment soon, he might never see again.
Carmen, the boy’s mother, desperately wished for her sons to see again, but could not afford the vision care that they needed. Thankfully, Carmen heard that SEE would be holding a free clinic in the nearby city of Tarapoto, in July 2017. Thanks to the incredible hard work of the traveling and in-country volunteer surgeons, Nacor received the cataract surgeries that he badly needed. Now he can see normally, participate in school, and play with his friends. He has a bright future ahead of him.
To view the multimedia release go to:
https://www.multivu.com/players/English/8282751-see-international-documentary-a-mothers-wish/